Metraipolis › archive › dc_276e1d040ffc
The association between SGLT2 inhibitors and rheumatoid arthritis risk in type 2 diabetes: findings from large-scale emulated target trials — Europe PMC PMID:42614254
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42614254
- DOI
- 10.3389/fimmu.2026.1867117
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T04:27:21.467Z
- SHA-256 of the archived text
4ce7119a4c9ceec9b1de2dbe97eca29ffbfe135df9e9f46c5b58a6f955f2d552- Stable URL of this page
https://metraipolis.com/documento/dc_276e1d040ffc
How to cite
The association between SGLT2 inhibitors and rheumatoid arthritis risk in type 2 diabetes: findings from large-scale emulated target trials — Europe PMC PMID:42614254 — Europe PMC (en), https://europepmc.org/article/MED/42614254 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_276e1d040ffc (Metraipolis archive dc_276e1d040ffc, sha256 4ce7119a4c9ceec9b1de2dbe97eca29ffbfe135df9e9f46c5b58a6f955f2d552)
BibTeX
@misc{dc276e1d040ffc,
title = {The association between SGLT2 inhibitors and rheumatoid arthritis risk in type 2 diabetes: findings from large-scale emulated target trials — Europe PMC PMID:42614254},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42614254},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_276e1d040ffc; sha256 4ce7119a4c9ceec9b1de2dbe97eca29ffbfe135df9e9f46c5b58a6f955f2d552},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42614254. Agents can read the archived copy with the MCP tool read_document.